A new aspect of tri-modal therapy with superselective intra-arterial chemotherapy in maxillary sinus carcinoma

Abstract

The local response rate with this combined therapy was 85.7%. Overall survival rates at 1 and 2 years were 78.6% and 56.2%, respectively, with median follow-up of 25.5 months.